4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cipla Limited (CIPLA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 31,369 employees. Its market capitalization is roughly ₹1.13 trillion. In the fiscal year ended 2026-03-31, CIPLA reported ₹277.1B in revenue and ₹38.8B in net income.
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | ₹277.1B | ₹271.5B | ₹254.5B | ₹224.7B |
| Gross Profit | ₹172.6B | ₹173.8B | ₹158.5B | ₹135.1B |
| Operating Income (EBIT) | ₹48.5B | ₹61.4B | ₹53.7B | ₹40.2B |
| Net Income | ₹38.8B | ₹52.7B | ₹41.2B | ₹28.0B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹70.8B | ₹64.6B | ₹69.6B | ₹68.4B | ₹66.0B | — |
| Gross Profit | ₹44.1B | ₹42.2B | ₹43.3B | ₹46.7B | ₹44.1B | — |
| Operating Income (EBIT) | ₹8.9B | ₹6.1B | ₹9.8B | ₹15.3B | ₹12.3B | — |
| Net Income | ₹7.9B | ₹5.5B | ₹6.8B | ₹13.0B | ₹12.2B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹12.9B) | (₹10.5B) | (₹6.9B) | (₹4.0B) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹425.0B | ₹373.9B | ₹327.2B | ₹294.6B | — |
| Total Liabilities | ₹79.8B | ₹61.0B | ₹59.2B | ₹57.5B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CIPLA viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms